WallStSmart
CLNN

Clene Inc.

NASDAQ: CLNN · CONSUMER DEFENSIVE · PACKAGED FOODS

$5.80
-0.85% today

Updated 2026-04-29

Market cap
$69.61M
P/E ratio
P/S ratio
348.05x
EPS (TTM)
$-2.65
Dividend yield
52W range
$2 – $14
Volume
0.1M

Clene Inc. (CLNN) Stock Valuation Analysis

Fair value estimate, historical valuation range, and quality signals for CLNN.

WallStSmart Verdict
Overvalued

Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.

Smart Value Score: 22 / 100
P/E (TTM)
Not meaningful for this profile
PEG
Margin of Safety
-67.89%
Fair value $2.46 vs $5.80
EV / EBITDA
0.0x

CLNN historical valuation range

Where current P/E sits in CLNN's own 5Y range.

Insufficient historical data for 5Y percentile analysis

CLNN intrinsic value (DCF)

DCF-based fair value estimate vs current market price.

Current price
$5.80
Market value
Intrinsic value
$2.46
DCF estimate
Margin of safety
-67.89%
-57.6% upside to fair value

Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.

CLNN valuation signals

Quick-read green flags, caution flags, and risks based on current metrics.

Premium to fair value
Price exceeds DCF intrinsic value by 67.9%. Limited downside protection.
Weak financial quality
Piotroski F-Score of 0/9 suggests deteriorating fundamentals. Valuation requires closer scrutiny.

P/E Ratio — History

P/S Ratio — History

Current: 348.05x

Is CLNN overvalued in 2026?

Clene Inc. (CLNN) currently trades at $5.80 per share with a market capitalization of $69,610,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 22/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.

CLNN currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 348.1x, the market is valuing the company primarily on its revenue rather than its earnings.

Our discounted cash flow model estimates CLNN's intrinsic value at $2.46 per share, against the current market price of $5.80. This implies a premium to fair value of -67.89%. The current price sits well above what projected cash flows justify, implying investors are paying for growth that has not yet materialized.

Financial quality is a concern. The Piotroski F-Score of 0/9 flags weakening fundamentals that deserve closer scrutiny before the valuation case can be fully trusted.

Bottom line: CLNN appears richly valued on our framework, with a Smart Value Score of 22/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.

Frequently asked questions

Is CLNN overvalued in 2026?

Based on a Smart Value Score of 22/100, CLNN appears overvalued. Current price exceeds what fundamentals currently justify.

What is CLNN's fair value?

Our DCF model estimates CLNN's intrinsic value at $2.46 per share, versus the current price of $5.80. This produces a margin of safety of -67.89%.

What P/E ratio does CLNN trade at?

CLNN does not have a meaningful P/E ratio at this time, typically a sign of unprofitability or an ongoing earnings transition.

Is CLNN a buy based on valuation?

WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 22/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.

How does CLNN's valuation compare to its history?

Insufficient historical valuation data exists yet for a confident percentile read on CLNN.

What is CLNN's Smart Value Score?

CLNN's Smart Value Score is 22/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.